TAYLOR REISMANN: Open Payments
NPI 1255989919 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 58 payments from 14 companies in 2025. Trend: 2023 $375 · 2024 $487 · 2025 $1,185
Food & beverage: $985Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $279 |
| ABBVIE INC. | 17 | $210 |
| UCB, Inc. | 7 | $153 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Organon LLC | 6 | $67 |
| Lilly USA, LLC | 3 | $65 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| GENZYME CORPORATION | 1 | $36 |
Products named: TREMFYA, Bimzelx, Sotyktu, SKYRIZI, LIBTAYO, TALTZ, RINVOQ, ILUMYA.
Industry payments across IA — which companies pay providers there.
